Defective Brca2 influences topoisomerase I activity in mammalian cells

Acta Biochimica Polonica

Volumn 50, Issue 1, 2003, Pages 139-144

  Rahden Staroń, Iwonna ^a,d   Szumiło, Maria ^a   Grosicka, Emilia ^a   Der Zwet, Maria Kraakman Van ^b   Zdzienicka, Małgorzata Z ^b,c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d NONE   (Poland)

Author keywords

Brca2 gene; Camptothecin; Topoisomerase I; V C8 mutant

Indexed keywords

BRCA2 PROTEIN; CAMPTOTHECIN; DNA TOPOISOMERASE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CHINESE HAMSTER; CHROMOSOME 13; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE FUNCTION; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; ONCOGENE;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA; MURINAE;

EID: 0042889164     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2003_3721     Document Type: Article

References (33)

1. Bradford MM. (1976) Anal Biochem.; 72: 248-54.
2. Bernstein C, Bernstein H, Payne CM, Garewald H. (2002) Mutat Res.; 511: 145-78.
3. Boothman DA, Trask DK, Pardee AB. (1989) Cancer Res.; 49: 605-12.
4. Boothaman DA, Wang M, Schea R, Burrows HL, Strickfaden S, Owens JK. (1992) Int J Rad Oncol Biol Phys.; 24: 938-48.
5. Champoux JJ. (2001) Annu Rev Biochem.; 70: 369-413.
6. Chaung W, Mi L-J, Boorstein R. (1997) Nucleic Acids Res.; 25: 992-4.
7. D'Arpa P, Liu LF. (1995) Exp Cell Res.; 217: 125-31.
8. Davies SM, Robson CN, Davies SL, Hickson JD. (1988) J Biol Chem.; 263: 17724-9.
9. Davies SM, Davies SL, Hall AG, Hickson JD. (1990) Mutat Res.; 235: 111-8.
10. Ferguson LR, Baguley BC. (1994) Environ Mol Mutagen.; 24: 245-61.
11. Ferro AM, Higgins NP, Olivera BM. (1983) J Biol Chem.; 258: 6000-3.
12. Frankenberg-Schwager M, Frankenberg D. (1990) Int J Radiat Biol.; 58: 569-75.
13. Gupta M, Fujimori A, Pommier Y. (1995) Biochim Biophys Acta.; 1262: 1-14.
14. Jonstone A, Mc Nerney R. (1985) Biosc Rep.; 5: 907-12.
15. Karran P. (2000) Curr Opin Genet Dev.; 10: 144-50.
16. Kim JM, Kim SH, Kolozsvary A, Khil MS. (1992) Int J Radiat Oncol Biol Phys.; 22: 515-8.
17. Kraakman-van der Zwet M, Overkamp WJ, van Lange RE, Essers J, van Duijn-Goedhart A, Wiggers I, Swaminathan S, van Buul PP, Errami A, Tan RT, Jaspers NG, Sharan SK, Kanaar R, Zdzienicka MZ. (2002) Cell Biol.; 22: 669-79.
18. Liu LF. (1983) Meth Enzymol.; 100: 133-7.
19. Overkamp WJ, Rooimans MA, Neuteboom I, Telleman P, Arwert F, Zdzienicka MZ. (1993) Somat Cell Mol Genet.; 19: 431-7.
20. Pommier Y, Kerrigan D, Hartman KD, Glazer RI. (1990) J Biol Chem.; 265: 9418-22.
21. Pommier Y, Leteurtre F, Fesen MR, Fujimori A, Bertrand R, Solary E, Kolhagen G, Kohen W. (1994) Cancer Invest.; 12: 530-42.
22. Rahman N, Stratton MR. (1998) Annu Rev Genet.; 32: 95-121.
23. Sambrook J, Fritsch E, Maniatis T. (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbour Laboratories, Cold Spring Harbour, NY.
24. Slichenmayer WJ, Rowinsky EK, Donehower RC, Kaufman SH. (1993) J Natl Cancer Inst.; 85: 271-91.
25. Thielmann HW, Popanda O, Gersbach H, Gilberg F. (1993) Carcinogenesis.; 14: 2341-51.
26. Trzcińska AM, Girstun A, Piekiełko A, Kowalska-Loth B, Staroń K. (2002) Mol Biol Rep.; 29: 347-52.
27. Verhaegh GW, Jongmans W, Morolli B, Jaspers NG, van der Schans GP, Lohman PH, Zdzienicka MZ. (1995) Mutat Res.; 337: 119-29.
28. Wang JC. (2002) Nat Rev Mol Cell Bio.; 3: 430-40.
29. Watt PM, Hickson ID. (1994) Biochem J.; 303: 681-95.
30. Weaver DT. (1996) Crit Rev Eukaryot Gene Expr.; 12: 530-42.
31. Xia F, Powell SN. (2002) Semin Radiat Oncol.; 12: 296-304.
32. Xia F, Taghian DG, DeFrank JS, Zeng Z-C, Willers H, Itiakis G, Powell SN. (2001) Proc Natl Acad Sci U S A.; 98: 8644-9.
33. Zdzienicka MZ. (1995) Mutat Res.; 336: 203-13.